Kiran Reddy retweeted
Epilepsy impacts the brain in various ways, causing seizures and other confusing symptoms. At Ionis, we’re working hard to make sense of this condition and bring some relief to those living with it. #EpilepsyAwarenessMonth
Congrats on the new gig at Jnana Therapeutics! @NickJBrandon73 ... finally leaving big pharma for the good life of biotech.
Great advice for biotech entrepreneurs also.
“Talent is insignificant. I know a lot of talented ruins. Beyond talent lie all the usual words: discipline, love, luck, but most of all, endurance.”
Baldwin's advice on writing brainpickings.org/2016/02/08…
Wow, a great example of the complexity of the brain we are just scratching the surface of in our therapeutic approaches.
Probably too simple to consider "serotonin neurons" to just be one thing nature.com/articles/s41583-0…
Hmmm...maybe time to start smoking?
There’s no link between #smoking and #dementia, a new study suggests. But that’s because many smokers die before dementia sets in. ms.spr.ly/6019T1gFS
Kiran Reddy retweeted
Today @GreenJournal published the positive Phase 2 #trofinetide results for #rettsyndrome, which showed "statistically significant" and "clinically relevant" improvements. We are grateful to everyone who helped move this compound forward. bit.ly/2FGoSsU #clinicaltrials
Kiran Reddy retweeted
How many schools have a pitch competition exclusively for women entrepreneurs? @Georgetown has that (going on now)-but get this: we also have a pitch comp open to all alumni -coming up at #jcw2019 -and ALL THE FINALISTS ARE WOMEN 😀 Proud of all our #hoyapreneurs #guwf19
Kiran Reddy retweeted
This is something we all struggle with when your child has a rare disorder. Sure, I want treatments. I want my daughter to have what all girls her age do. But she’s also perfect just as she is. You can hold both truths.
A piece Sally wrote featured on @TheMightySite yesterday. I am blessed to have an amazing family and an amazing wife who’s strength is so far beyond measure. themighty.com/2018/04/findin…
Kiran Reddy retweeted
Over 3,000 genetic conditions affect the neurological system. 75% of these conditions affect babies and children.CNF & @GlobalGenes along w/ their partners have teamed up to better understand this community. YOU ARE NOT ALONE Rare Child Neurology Workgroup buff.ly/2L8VIUn
There has been lots of criticism of $BIIB and I won't refute it BUT it is important to highlight their boldness and dedication to work on difficult CNS diseases that most other companies have run away from. We must not be discouraged.
“This disappointing news confirms the complexity of treating Alzheimer’s disease and the need to further advance knowledge in neuroscience,” said Biogen CEO Michel Vounatsos in a prepared statement - by @BentheFidler xconomy.com/boston/2019/03/2… $BIIB
Kiran Reddy retweeted
According to Tom Stanton of @DannyDidOrg, 90-95% of parents whose children have epilepsy want to know about the risk of SUDEP. Share this episode of Seizing Life to spread #SUDEPawareness: seizinglife.org/sudep-what-y… #PutPatientsFirst
Kiran Reddy retweeted
#Boston: Save the date for an inspired #artexhibition, featuring work by artists with epilepsy. Learn more here: cureepilepsy.org/event_type/…
Congrats SAGE! @SageBiotech
FDA approves first new drug, as a breakthrough therapy, specifically for the treatment of postpartum depression (#PPD), pending DEA scheduling. See full announcement: bit.ly/2WeD0ir $SAGE
Kiran Reddy retweeted
For people with a rare condition known as misophonia, certain sounds like slurping, chewing, tapping and clicking can elicit intense feelings of rage or panic. npr.org/sections/health-shot…
Kiran Reddy retweeted
Great day at @TheFlorey - and great news that @reddykMD and Praxis are here in #Melbourne @Kcnq2Cure @geneticepilepsy #kcnq2 #neuroscience
Praxis Precision Medicines is developing drugs to improve the lives of millions - and they’ll do it right here in Victoria. More jobs, more investment, more good news for Victoria #springst premier.vic.gov.au/more-jobs…
Kiran Reddy retweeted
Great team effort on this @Health_Affairs study that we believe shows we are still in the midst of a “validation phase” of digital health: Kyan Safavi @MGHMedicine, @simoncmathews1 @HopkinsMedicine, @DBatesSafety @BrighamWomens, Ray Dorsey @UofR
Digital #health companies have minimal impact on disease burden & #healthcare costs according to a new study. The findings indicate the importance of building products/services that provide value for high-cost, high-burden patients. bit.ly/2AzXGsS @adambriancohen
































